SCHEMBL8779541

SCHEMBL8779541

Cc1ccccc1N(C(=O)O)c1ccccc1C

nearest known ligand 0.55

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
TRPM8 Q7Z2W7 1/20 0.51
LMNA P02545 2/20 0.44
CYP3A4 P08684 2/20 0.43
TEAD1 P28347 1/20 0.42
KMT2A Q03164 2/20 0.42
TP53 P04637 3/20 0.41
HSD17B1 P14061 1/20 0.41
HSD17B2 P37059 1/20 0.41
MEN1 O00255 1/20 0.41
TSHR P16473 3/20 0.40
MAPK1 P28482 1/20 0.40
NPSR1 Q6W5P4 1/20 0.39
ACHE P22303 1/20 0.39
ALDH1A1 P00352 2/20 0.39
GAA P10253 1/20 0.39
MAPT P10636 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
NPC1 O15118 1/20 0.39
RAB9A P51151 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2092543 0.90 TRPM8 (0.51) TRPM8LMNACYP3A4TEAD1KMT2A
SCHEMBL9547533 0.84 NPSR1 (0.46) TRPM8LMNACYP3A4TP53HSD17B1
SCHEMBL7869606 0.83 TRPM8 (0.40) TRPM8LMNAKMT2AHSD17B1HSD17B2
SCHEMBL22917037 0.82 LMNA (0.53) TRPM8LMNACYP3A4KMT2AHSD17B1
SCHEMBL11219021 0.81 TRPM8 (0.47) TRPM8LMNAKMT2AHSD17B1HSD17B2
SCHEMBL28333244 0.81 ALDH1A1 (0.46) TRPM8LMNACYP3A4KMT2ATP53
SCHEMBL1029152 0.80 TRPM8 (0.50) TRPM8LMNAKMT2AHSD17B1HSD17B2
SCHEMBL1954826 0.80 SIGMAR1 (0.44) TRPM8LMNACYP3A4TP53HSD17B1
SCHEMBL8187602 0.80 TRPM8 (0.50) TRPM8LMNACYP3A4TEAD1KMT2A
Benzene SCHEMBL28335658 0.80 TRPM8 (0.50) TRPM8LMNAKMT2AHSD17B1HSD17B2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2378601-B1 ELECTROLYTE CONTAINING A EUTECTIC MIXTURE AND A SPECIFIC NITRILE COMPOUND, AND ELECTROCHEMICAL DEVICE COMPRISING THE SAME LG CHEMICAL LTD (KR) 2016-03-30 EP claimed
US-9567307-B2 Amination of aryl alcohol derivatives THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2017-02-14 US disclosed
US-20130289270-A1 Amination of Aryl Alcohol Derivatives THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2013-10-31 US disclosed
WO-2012094622-A2 AMINATION OF ARYL ALCOHOL DERIVATIVES THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2012-07-12 WO disclosed
EP-0525197-B1 3-BENZYLIDENE-1-CARBAMOYL-2-PYRROLIDONE ANALOGS SHIONOGI & CO (JP) 1997-08-27 EP disclosed
US-5319100-A Antiinflammatory agent which does not cause stomach diseases SHIONOGI SEIYAKU KABUSHIKI KAISHA (JP) 1994-06-07 US disclosed
US-5319099-A Antiinflammatory agent which does not cause stomach diseases SHIONOGI SEIYAKU KABUSHIKI KAISHA (JP) 1994-06-07 US disclosed
EP-0525197-A1 3-BENZYLIDENE-1-CARBAMOYL-2-PYRROLIDONE ANALOG SHIONOGI SEIYAKU KABUSHIKI KAISHA (JP) 1993-02-03 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130289270-A1 Amination of Aryl Alcohol Derivatives SULT2A1, SULT1A1, ADH5 TRPM8 4783/4885LMNA 2947/4885CYP3A4 55/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.